NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health & Medicine Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health & Medicine Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Antibiotic Resistance



Newly discovered inhibitors of bacterial lactamases may prevent resistance



September 1st, 2003

The most important antibiotics in general use today are the b-lactam family of products, but the medical community faces a serious problem with these antibiotics: the increasing development of drug resistance.

The resistance is caused by hydrolysis of the b-lactam by a bacterial lactamase enzyme, but fortunately it can often be overcome by the use of a serine b-lactamase inhibitor in combination with the drug. This approach is successfully used already; for example clavulanic acid is used in combination with amoxycillin in Augmentin.

Unfortunately, various b-lactam drugs are also inactivated by metallo-b-lactamases, which cannot be overcome by the...


Source: Health & Medicine Week (2003-09-01)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login